Bridge GLP compliant drug development in the US & China

Articles

Offshore Opportunity on the Rise

Mar 1, 2008

By:Jim Miller

BioPharm International

 

China continues to get a lot of bad press for quality problems with some medications and other consumer products manufactured there, but its popularity as a place to conduct biopharmaceutical research continues to grow. The major clinial research organizations (CROs) are racing to get established there, as much to stay a step ahead of the competition as for the immediate opportunity.  Read more...